Eye and Vision Research Institute

Icahn School of Medicine at Mount Sinai

900 - 925 out of 1,026 results
- Title
- Date(ascending)

Nyu Emergency Medicine Residency Twitter
Rosen, R.
26/09/19
1 item of Media coverage
Press/Media
Bad news for chocolate lovers: it may not help your vision
Lema, G.
26/09/19
1 item of Media coverage
Press/Media
Bad news for chocolate lovers: it may not help your vision
Lema, G.
26/09/19
6 items of Media coverage
Press/Media
Bad news for chocolate lovers: it may not help your vision
Lema, G.
26/09/19
2 items of Media coverage
Press/Media
Bad news for chocolate lovers: it may not help your vision
Lema, G.
26/09/19
1 item of Media coverage
Press/Media
Sept. 23 Financial Quick Takes: Innate looks to add U.S. listing; plus Curamir's launch, Qihan Bio and Vedanta
Chen, B.
24/09/19
1 item of Media coverage
Press/Media
Curamir Therapeutics Raises $10M in Series A Funding
Chen, B.
23/09/19
1 item of Media coverage
Press/Media
Curamir Therapeutics Secures $10M Series A
Chen, B.
23/09/19
1 item of Media coverage
Press/Media
Delos Capital Raises $10M Series A
Chen, B.
22/09/19
1 item of Media coverage
Press/Media
Don't Let Shingles Harm Your Vision: This painful condition is most common in seniors, and can cause potentially serious complications.(VISION)
Ahmad, S.
21/09/19
1 item of Media coverage
Press/Media
Delos Capital Announces the Launch of Curamir Therapeutics Inc. with a $10 Million Series A to Develop miRNA-based Cancer Therapeutics
Chen, B.
20/09/19
3 items of Media coverage
Press/Media
Simple Limbal Epithelial Transplantation
Masako Chen
20/09/19
1 item of Media coverage
Press/Media
Delos Capital Announces the Launch of Curamir Therapeutics Inc. with a $10 Million Series A to Develop miRNA-based Cancer Therapeutics
Chen, B.
20/09/19
8 items of Media coverage
Press/Media
Delos Capital Announces the Launch of Curamir Therapeutics Inc. with a $10 Million Series A to Develop miRNA-based Cancer Therapeutics
Chen, B.
20/09/19
1 item of Media coverage
Press/Media
Delos Capital Announces the Launch of Curamir Therapeutics Inc. with a $10 Million Series A to Develop miRNA-based Cancer Therapeutics
Chen, B.
20/09/19
1 item of Media coverage
Press/Media
Delos Capital Announces the Launch of Curamir Therapeutics Inc. with a $10 Million Series A to Develop miRNA-based Cancer Therapeutics
Chen, B.
20/09/19
1 item of Media coverage
Press/Media
Delos Capital Announces the Launch of Curamir Therapeutics Inc. with a $10 Million Series A to Develop miRNA-based Cancer Therapeutics
Chen, B.
20/09/19
1 item of Media coverage
Press/Media
MicroRNA-based Therapy May be New Weapon to Combat Cancer
Chen, B.
19/09/19
1 item of Media coverage
Press/Media
Microrna-based therapy may prove to be effective against chemotherapy-resistant cancers
Chen, B.
19/09/19
1 item of Media coverage
Press/Media
MicroRNA-based Therapy May be New Weapon to Combat Cancer
Chen, B.
18/09/19
1 item of Media coverage
Press/Media
Zacks: Analysts Anticipate Eyenovia Inc (NASDAQ:EYEN) Will Announce Earnings of -$0.41 Per Share
Ianchulev, T.
9/09/19
1 item of Media coverage
Press/Media
WIPO PUBLISHES PATENT OF THE SCHEPENS EYE RESEARCH INSTITUTE FOR "VISUAL FIELD PROGRESSION" (AMERICAN INVENTORS)
Pasquale, L.
8/09/19
1 item of Media coverage
Press/Media
Mount Sinai Research Suggests Retinal Vein Occlusion is linked to Heart Disease and Stroke
Deobhakta, , A.
6/09/19
1 item of Media coverage
Press/Media
MEDIA ADVISORY: Mount Sinai Research Suggests Retinal Vein Occlusion is linked to Heart ...
Deobhakta, , A.
5/09/19
1 item of Media coverage
Press/Media
Mount Sinai Research Suggests Retinal Vein Occlusion is linked to Heart Disease and Stroke
Deobhakta, , A.
5/09/19
1 item of Media coverage
Press/Media